BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10527353)

  • 21. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
    Janjan NA; Abbruzzese J; Pazdur R; Khoo VS; Cleary K; Dubrow R; Ajani J; Rich TA; Goswitz MS; Evetts PA; Allen PK; Lynch PM; Skibber JM
    Radiother Oncol; 1999 May; 51(2):153-60. PubMed ID: 10435807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.
    Videtic GM; Fisher BJ; Perera FE; Bauman GS; Kocha WI; Taylor M; Vincent MD; Plewes EA; Engel CJ; Stitt LW
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):319-24. PubMed ID: 9788410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers.
    Lim YK; Law WL; Liu R; Poon JT; Fan JF; Lo OS
    World J Surg Oncol; 2010 Mar; 8():23. PubMed ID: 20346160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
    Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
    Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
    Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
    Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
    Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
    Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
    Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
    Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
    Gérard JP; Chapet O; Nemoz C; Romestaing P; Mornex F; Coquard R; Barbet N; Atlan D; Adeleine P; Freyer G
    J Clin Oncol; 2003 Mar; 21(6):1119-24. PubMed ID: 12637479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
    Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
    Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.
    Habr-Gama A; Perez RO; Nadalin W; Sabbaga J; Ribeiro U; Silva e Sousa AH; Campos FG; Kiss DR; Gama-Rodrigues J
    Ann Surg; 2004 Oct; 240(4):711-7; discussion 717-8. PubMed ID: 15383798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.
    Cambray i Amenós M; Navarro García M; Martí Ragué J; Pareja Fernández L; Pera Fábregas J
    Clin Transl Oncol; 2007 Mar; 9(3):183-91. PubMed ID: 17403630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma.
    Luna-Pérez P; Rodríguez-Ramírez S; Rodriguez-Coria DF; Fernández A; Labastida S; Silva A; López MJ
    World J Surg; 2001 Aug; 25(8):1006-11. PubMed ID: 11571965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
    Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.